In fact, inhibition of SHMT1 and SHMT2 recapitulated gene expression changes associated with MYC inhibition and may contribute to the differential sensitivity of T-ALL to one-carbon folate pathway inhibition. The gene discussed is MYC; the disease is acute lymphoblastic leukemia.